Form 4: Hims & Hers Health, Inc. Director Carroll Sells Shares and Acquires Restricted Stock Units

Director and Chief Medical Officer Patrick Harrison Carroll sold 20,000 shares of Hims & Hers Health, Inc. and acquired 77,433 restricted stock units.

Summary

• On February 28, 2024, Patrick Harrison Carroll, a Director and Chief Medical Officer of Hims & Hers Health, Inc., sold 20,000 shares of Class A Common Stock at a price of $13.19 per share.
• Following this transaction, Carroll directly owns 154,835 shares of Class A Common Stock.
• On the same day, Carroll acquired 77,433 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Class A Common Stock.
• These RSUs vest over a 4-year period in substantially equal quarterly installments, starting on June 15, 2024.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's future.

Future Outlook

The RSUs vest over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a 'Company Quarterly Vesting Date'), with the first such vesting date on June 15, 2024.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings to gain insights into management's perspective on the company's stock.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, depending on the overall market reaction.
• The RSU grant aligns management's interests with those of shareholders by incentivizing long-term value creation.

Key Dates